Prestige Consumer Healthcare Inc
PBH: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$92.00 | Kqljqqd | Hkrsjqzhj |
Product Issues Hurt Prestige's 2Q
Prestige Brands Holdings PBH is currently facing a number of problems, which separately do not give us much cause for concern, but collectively give us pause. We are placing the stock under review as we assess the firm's second-quarter earnings and statements regarding the company's voluntary withdrawal of pediatric cold and cough medications, as well as current litigation involving the firm. We do not anticipate a substantial change to our fair value estimate, but given the firm's deteriorating stock price we want to review the assumptions behind our outlook for Prestige to determine whether we are comfortable recommending the shares.